LITES Task Order 0005 Prehospital Airway Control Trial (PACT) (PACT)

April 9, 2026 updated by: Jason Sperry

Prehospital Airway Control Trial : A Randomized Controlled Trial of Prehospital Airway Management Strategy for Trauma Patients

The Prehospital Airway Control Trial (PACT) is a proposed 5 year, open label, multi-center, stepped-wedge randomized trial comparing airway management strategies of prehospital trauma patients. The initial airway attempt will be randomized to either usual care (control) or a supraglottic airway management approach (intervention). The primary outcome will be 24 hour survival, with secondary outcomes to include survival to hospital discharge, expected clinical adverse events, airway management performance, ICU length of stay, ventilator days, incidence of ARDS, and incidence of ventilator associated pneumonia. Subjects will be enrolled across approximately 17 prehospital agencies at select LITES Network sites and will enroll a total of 2,009 subjects.

Study Overview

Study Type

Interventional

Enrollment (Actual)

2010

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30303
        • Emory University
    • Illinois
      • Chicago, Illinois, United States, 60637
        • University of Chicago
      • Chicago, Illinois, United States, 60611
        • Northwestern Memorial Hospital
      • Chicago, Illinois, United States, 60612
        • John H. Stroger Hospital of Cook County
      • Chicago, Illinois, United States, 60608
        • Mount Sinai Hospital
    • Kentucky
      • Louisville, Kentucky, United States, 40208
        • University of Louisville
    • Louisiana
      • New Orleans, Louisiana, United States, 70112
        • Tulane University
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Washington University at St. Louis
    • North Carolina
      • Greenville, North Carolina, United States, 27835
        • East Carolina University
    • Oregon
      • Portland, Oregon, United States, 97239
        • Oregon Health & Science University
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • University of Pittsburgh
      • Pittsburgh, Pennsylvania, United States, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, United States, 15261
        • UPMC
    • Tennessee
      • Nashville, Tennessee, United States, 37235
        • Vanderbilt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Traumatic injury requiring advanced airway management. Indicators of need for advanced airway management include: a) GCS<8, b) SpO2<90 despite supplemental oxygen, b) ETCO2>60 despite supplemental ventilation, or d) provider discretion.
  2. Transport (or intended transport) to an enrolling LITES Trauma Center

Exclusion Criteria:

  1. < 15 years of age
  2. Known pregnancy
  3. Known prisoner
  4. Initial advanced airway attempted by a non-PACT provider.
  5. Cardiac Arrest without return of spontaneous circulation (ROSC) at the time of the intervention
  6. Caustic substance ingestion
  7. Airway burns
  8. Objection to study voiced by subject or family member at the scene.

Inclusion and exclusion criteria will be assessed based on information available at the time of enrollment, defined as the time at which enrolling agency provides positive pressure ventilation support. Although all reasonable efforts will be made by the emergency medical crew to either directly witness or obtain documentation of inclusion criteria, due to the nature of the emergency prehospital setting, there may be occasions where the emergency medical crew must rely on verbal report of inclusion criteria from referring hospital or emergency crew. In these instances, if, after subsequent review of outside hospital and/or ground crew documentation, it is determined that the subject did not meet inclusion criteria and/or met exclusion criteria, the subject will remain enrolled in the study based on the intention-to-treat principle.

If a verbal report must be used in lieu of physical documentation or directly witnessing inclusion criteria, documentation of the verbal report will serve as the source documentation for determining eligibility. Verbal reports will be documented in the emergency medical record and will detail the information provided and by whom.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard airway method arm
Standard airway management strategy
Initial advanced airway management with standard care method
Experimental: Supraglottic airway method arm
Supraglottic first airway management strategy
Initial advanced airway management with a supraglottic device
Other Names:
  • LMA
  • King
  • igel

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
24-hour survival
Time Frame: From injury through 24 hours
From injury through 24 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Proportion of subjects that survive to hospital discharge
Time Frame: From hospital admission through death or hospital discharge up to 30 days
From hospital admission through death or hospital discharge up to 30 days
Rate of first pass success of placement of advanced airway device
Time Frame: At time of placement of device through confirmation of device placement
At time of placement of device through confirmation of device placement
ICU length of stay
Time Frame: Admission through 30 days or discharge
Admission through 30 days or discharge
Ventilator days
Time Frame: Admission through 30 days or discharge
Admission through 30 days or discharge
Incidence of expected adverse events
Time Frame: From initial airway management through first 24 hours of hospital admission
From initial airway management through first 24 hours of hospital admission
Incidence of need for rescue airway device
Time Frame: At the time of placement of device through time of arrival to trauma bay
At the time of placement of device through time of arrival to trauma bay
Incidence of hypoxia
Time Frame: At the time of placement of device through time of arrival to trauma bay
At the time of placement of device through time of arrival to trauma bay
Incidence of hypotension
Time Frame: At the time of placement of device through time of arrival to trauma bay
At the time of placement of device through time of arrival to trauma bay

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Jason Sperry, MD, MPH, University of Pittsburgh
  • Principal Investigator: Francis Guyette, MD, MPH, University of Pittsburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

March 7, 2026

Study Completion (Actual)

April 7, 2026

Study Registration Dates

First Submitted

September 11, 2019

First Submitted That Met QC Criteria

September 20, 2019

First Posted (Actual)

September 24, 2019

Study Record Updates

Last Update Posted (Actual)

April 14, 2026

Last Update Submitted That Met QC Criteria

April 9, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY20110369
  • W81XWH- 16-D- 0024 (Other Grant/Funding Number: Department of Defense)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma Injury

Clinical Trials on Standard airway management

Subscribe